Nucleus RadioPharma secured a Series A extension funding with AstraZeneca investment.
Round Type
Series A
DavidsonManufacturingBiotechnologyHealth CarepharmaceuticalsInvestors
Description
Nucleus RadioPharma announced the closing of a Series A extension round with new investor AstraZeneca, joining existing investors GE Healthcare, Mayo Clinic, and others. The funding will be used to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible to patients globally.
Quick answer
Nucleus RadioPharma raised an undisclosed amount in a Series A round, dated June 5, 2024. Investors: University Of Missouri, Echo Global Granger Management Mercy Health, Fox Chase Cancer Center, Eclipse Ventures, Mayo Clinic, GE Healthcare and Astra Zeneca. Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- How much did Nucleus RadioPharma raise?
- Nucleus RadioPharma raised an undisclosed amount in a Series A round on June 5, 2024.
- Who invested in Nucleus RadioPharma?
- University Of Missouri, Echo Global Granger Management Mercy Health, Fox Chase Cancer Center, Eclipse Ventures, Mayo Clinic, GE Healthcare and Astra Zeneca are named as investors in this round.
- What does Nucleus RadioPharma do?
- Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies.
- Where is Nucleus RadioPharma based and how big is it?
- Nucleus RadioPharma is based in Davidson, North Carolina, United States. Fundz records about 46 employees.
- Who are the decision-makers at Nucleus RadioPharma?
- Fundz holds 1 contact at Nucleus RadioPharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Nucleus RadioPharma, and when
A new round usually means Nucleus RadioPharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNucleus RadioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.